Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Craig E. Fraser$3.7M
Market Cap • 17/04/20241992
(há 32 anos)
1984
(40 years ago)
NASDAQ
Listagem
Warrington
Sede • Pennsylvania20
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
WINTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.